Raltegravir Cerebrospinal Fluid Concentrations in HIV-1 Infection

INTRODUCTION: Raltegravir is an HIV-1 integrase inhibitor currently used in treatment-experienced HIV-1-infected patients resistant to other drug classes. In order to assess its central nervous system penetration, we measured raltegravir concentrations in cerebrospinal fluid (CSF) and plasma in subj...

Descripción completa

Detalles Bibliográficos
Autores principales: Yilmaz, Aylin, Gisslén, Magnus, Spudich, Serena, Lee, Evelyn, Jayewardene, Anura, Aweeka, Francesca, Price, Richard W.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2731205/
https://www.ncbi.nlm.nih.gov/pubmed/19721718
http://dx.doi.org/10.1371/journal.pone.0006877

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2731205/
https://www.ncbi.nlm.nih.gov/pubmed/19721718
http://dx.doi.org/10.1371/journal.pone.0006877

Ejemplares similares